logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Boehringer Ingelheim acquires Saiba Animal Health AG to boost pet therapeutics R&D

Sep 03, 2024•over 1 year ago

Acquiring Company

Boehringer Ingelheim

Acquired Company

Saiba Animal Health AG

Ingelheim am RheinZurichpharmaceuticalsPharmaceuticalMedicalBiotechnologyHealth Care

Description

Boehringer Ingelheim has completed the acquisition of Saiba Animal Health AG, a company focused on the development of novel therapeutic medicines to address chronic diseases in pets. With this acquisition, Boehringer Ingelheim strengthens its animal health research and development (R&D) pipeline, specifically in the fast-growing pet therapeutics category.

Company Information

Company

Boehringer Ingelheim

Location

173 Binger Strasse

Ingelheim am Rhein, Rhineland-Palatinate, Germany

About

Boehringer Ingelheim International GmbH is a multinational pharmaceutical company that has transferred the rights of three anti-diabetes trademarks—Gibtulio, Gibtulio Met, and Ajaduo—to Lupin Limited.

Related People

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed